1. Neural respiratory drive predicts long-term outcome following admission for exacerbation of COPD: a post hoc analysis
- Author
-
Maxime Patout, Georgios Kaltsakas, Elodie Lhuillier, Rebecca D'Cruz, Nicholas Hart, Patrick B. Murphy, Eui-Sik Suh, Gill Arbane, and Leonor Meira
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Multivariate analysis ,Exacerbation ,Pulmonary Disease, Chronic Obstructive ,Cause of Death ,Internal medicine ,Post-hoc analysis ,Humans ,Medicine ,Prospective Studies ,Aged ,COPD ,Electromyography ,business.industry ,medicine.disease ,Survival Analysis ,United Kingdom ,Respiratory Function Tests ,Hospitalization ,Respiratory failure ,Parasternal line ,Control of respiration ,Disease Progression ,Female ,business ,Cohort study - Abstract
Neural respiratory drive (NRD), as reflected by change in parasternal muscle electromyogram (EMGpara), predicts clinical deterioration and safe discharge in patients admitted to hospital with an acute exacerbation of COPD (AECOPD). The clinical utility of NRD to predict the long-term outcome of patients following hospital admission with an AECOPD is unknown. We undertook a post hoc analysis of a previously published prospective observational cohort study measuring NRD in 120 patients with AECOPD. Sixty-nine (57.5%) patients died during follow-up (median 3.6 years). Respiratory failure was the most common cause of death (n=29; 42%). In multivariate analysis, factors independently associated with an increased mortality included NRD (HR 2.14, 95% CI 1.29 to 3.54, p=0.003), age (HR 2.03, 95% CI 1.23 to 3.34, p=0.006), PaCO2 at admission (HR 1.83, 95% CI 1.06 to 3.06, p=0.022) and long-term oxygen use (HR 2.98, 95% CI 1.47 to 6.03, p=0.002). NRD at hospital discharge could be measured in order to assess efficacy of interventions targeted to optimise COPD and reduce mortality following an AECOPD.Original clinicaltrial.gov number:NCT01361451
- Published
- 2019
- Full Text
- View/download PDF